#cmrx

Chimerix (CMRX:NAS) Fundamental Valuation Report

Fundamental Valuation Report Chimerix(CMRX:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$8.25 (USD) 04/21/2021 Weighted Valuation$6.79 (USD) Overall RatingOvervalued by 17.8% Valuation Models Comparables: $6.79 (USD) Valuation Methods This company is: Cash…

Chimerix Inc (Nasdaq:CMRX) Lowers The 52 Week Low

Chimerix Inc (Nasdaq:CMRX)

October 23rd, 2018

Amidst falling markets Chimerix Inc fell $0.06 Tuesday, down 1.69%, closing at $3.48. As well as the drop in value, Chimerix Inc hit a new 52 week low of $3.38, breaking the previous low of $3.52 from earlier this month. In addition to the stock finishing lower, the trading volumes were only 48% of normal which could be an indication of investor…

Dropping The 52 Week Low, Chimerix Inc (Nasdaq:CMRX) Finishing At $3.54

Chimerix Inc (Nasdaq:CMRX)

October 22nd, 2018

Chimerix Inc fell $0.06 Monday, down 1.67%, closing at $3.54. As well as the drop in value, Chimerix Inc hit a new 52 week low of $3.52, breaking the previous low of $3.53 from earlier this month. The next earnings report is expected in approximately 15 days. (more…)

Lowering The 52 Week Low, Chimerix Inc (Nasdaq:CMRX) Closing Trading At $3.58

Chimerix Inc (Nasdaq:CMRX)

September 13th, 2018

Amidst rising markets Chimerix Inc finished Thursday’s trading session down 4.53%, a $0.17 decrease to close on $3.58. As well as the drop in value, Chimerix Inc hit a new 52 week low of $3.57, breaking the previous low of $3.70 from earlier this month. Despite the drop in value, trading volumes were solid at 220% of normal which can indicate…

Lowering The 52 Week Low, Chimerix Inc (Nasdaq:CMRX) Close At $3.75

Chimerix Inc (Nasdaq:CMRX)

September 6th, 2018

Chimerix Inc fell $0.25 Saturday, a 6.14% drop, closing at $3.75. As well as the drop in value, Chimerix Inc hit a new 52 week low of $3.74, breaking the previous low of $3.85 from earlier this month. Be aware that the Piotroski Score1 is calculated to be 2, which is very low as the scale goes from 0-9. This is considered to be a weak score in terms…

Breaking The Old 52 Week Low, Chimerix Inc (Nasdaq:CMRX) Closing At $3.90

Chimerix Inc (Nasdaq:CMRX)

September 4th, 2018

Amidst falling markets Chimerix Inc fell $0.09 Monday, a 2.26% decline, closing at $3.90. As well as the drop in value, Chimerix Inc hit a new 52 week low of $3.85, breaking the previous low of $3.95 from earlier this April. Be aware that the Piotroski Score1 is calculated to be 2, which is very low as the scale goes from 0-9. This is considered to…

Chimerix, Inc. (NASDAQ:CMRX) Files An 8-K Regulation FD Disclosure

Chimerix, Inc. (NASDAQ:CMRX) Files An 8-K Regulation FD Disclosure Item7.01 Regulation FD Disclosure. Attached hereto as Exhibit 99.1 and incorporated herein by reference is a corporate update presentation to be utilized by Chimerix, Inc. at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco, California. The information in this Item 7.01 and the attached Exhibit 99.1 is being…

Stemline Therapeutics Inc. (NASDAQ:STML), Chimerix Inc. (NASDAQ:CMRX) and Castlight Health Inc. (NYSE:CSLT) are this Tuesday’s top midday gainers. On the losing end are 21Vianet Group Inc. (NASDAQ:VNET), Empire Resorts Inc. (NASDAQ:NYNY) and Sears Hometown and Outlet Stores Inc. (NASDAQ:SHOS).